🇺🇸 FDA
Patent

US 10197577

Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

granted A61KA61K2039/521A61K2039/522

Quick answer

US patent 10197577 (Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/521, A61K2039/522, A61K2039/54, A61K39/015